Sherry Fox appointed BioCare Systems CEO

Wednesday November 16, 2016 Tags: Parker, Sherry Fox, BioCare Systems, Lumiwave, Jon Weston

PARKER -- BioCare Systems, Inc. announced Sherry Fox will resume the position of CEO and president of BioCare Systems, Inc., a company devoted to helping people get better, faster through its patented near infrared (NIR) light therapy device, LumiWave.

Fox also serves as chairman of the company’s board. Most recently she served as chief business development officer for the company. In her new position, Fox is responsible for overseeing all aspects of product development for the LumiWave device, including manufacturing and regulatory affairs, distribution, sales, financial operations and investor relations.

"There is a $300 billion painkiller industry, where side effects are well documented such as possible liver damage, to name just one," said Fox.

"Our goal is to show those living with pain, from a variety of afflictions, that clinical grade relief, previously only available in special facilities or with expensive equipment, is now available to consumers in the comfort and privacy of their own home at an affordable price, without the side effects of drugs."

As BioCare continues to evolve and innovate in the infrared technology space, Jon Weston, formerly company CEO and president, will be taking on the new roles of chief marketing officer and chief science officer.

Through his role as CMO, Weston is tasked with finding and creating high-profile partnerships with recognized sports medicine pioneers and various athletic teams and athletes of all levels.

He will also be responsible for finding ambassadors for the brand that will benefit from the uses of the LumiWave device and might offer their testimonial and personal endorsement of the product.

Through Weston’s role as CSO, he will strive to prepare BioCare Systems for the next evolution of product development through his outreach and partnerships with influential opinion leaders and doctors in the infrared technology research space, in order to broaden understanding of the science behind this evolving technology.

Prior to serving as the CEO and president of BioCare Systems, Weston was VP of operations for the company.

“In my new role I will be working and innovating in a field that promises to improve the health of our customers,” Weston said.

“BioCare Systems will continue revolutionizing a new and upcoming field alongside the greatest doctors, researchers, athletes and thought leaders in the world.”